Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review)
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5599 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Xiaotong Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Histone Deacetylases. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cardiovascular disease (CVD) is a major global health threat, as its incidence and mortality rates continue to rise, highlighting the urgent need for effective therapeutic strategies. Histone deacetylase 4 (HDAC4), a member of class IIa HDACs, has attracted increasing attention in recent years for its role in CVD. Studies have shown that HDAC4 can influence the development and progression of CVD such as cardiac hypertrophy, hypertension and atherosclerosis by regulating key pathophysiological processes including inflammation, fibrosis and apoptosis. The present review focuses on the functional roles of HDAC4 in CVD and examines the effects of pharmacological agents and physical exercise on its expression. Future research should further elucidate the molecular mechanisms underlying HDAC4's involvement in CVD to provide new theoretical foundations for clinical diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China.
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China.
- Department of Rehabilitation and Physiotherapy, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, Shandong 250011, P.R. China.
Zitieren
APA
Ma, X., Wei, R., Song, A., Zhang, X., Zou, J., & Hao, S. (2025). Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5599
Vancouver
Ma X, Wei R, Song A, Zhang X, Zou J, Hao S. Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review). International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5599
BibTeX
@article{Ma2025,
author = {Ma, Xiaotong and Wei, Ran and Song, Anni and Zhang, Xinyi and Zou, Jianpeng and Hao, Shijie},
title = {Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review)},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5599}
}
EUVIMED